LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS

Goebell P, Shah R, Raina R, Rege S, Chen S, Partridge J, Waldeck R (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Value in Health Wiley-Blackwell: No OnlineOpen / Elsevier

Publisher: ELSEVIER SCIENCE INC

City/Town: NEW YORK

Pages Range: S497-S497

Conference Proceedings Title: VALUE IN HEALTH

DOI: 10.1016/j.jval.2022.04.1101

Authors with CRIS profile

Peter Goebell Urologische Klinik

Involved external institutions

Bayer HealthCare Pharmaceuticals Inc. US United States (USA) (US) OPEN Health US United States (USA) (US)

How to cite

APA:

Goebell, P., Shah, R., Raina, R., Rege, S., Chen, S., Partridge, J., & Waldeck, R. (2022). LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS. In VALUE IN HEALTH (pp. S497-S497). NEW YORK: ELSEVIER SCIENCE INC.

MLA:

Goebell, Peter, et al. "LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS." Proceedings of the VALUE IN HEALTH NEW YORK: ELSEVIER SCIENCE INC, 2022. S497-S497.

BibTeX: Download